Validation of a Novel CHX-A‘ ‘ Derivative Suitable for Peptide Conjugation: Small Animal PET/CT Imaging Using Yttrium-86-CHX-A‘ ‘-Octreotide
- 20 June 2006
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (14) , 4297-4304
- https://doi.org/10.1021/jm060317v
Abstract
A versatile bifunctional chelating reagent based on a preorganized cyclohexyl derivative of DTPA (CHX-A'') has been developed for the convenient N-terminal labeling of peptides with metal ion radionuclides of Bi(III), In(III), Lu(III), or Y(III). This was achieved via the synthesis of a mono-N-hydroxysuccinimidyl penta-tert-butyl ester derivative of CHX-A'' (trans-cyclohexyldiethylenetriaminepenta-acetic acid) featuring a glutaric acid spacer. Commercially obtained octreotide was modified at its N-terminus by this reagent in the solution phase, and its subsequent radiolabeling with (111)In (T(1/2) = 2.8 d) and (86)Y (T(1/2) = 14.7 h) demonstrated. Small animal PET/CT imaging results of (86)Y-CHX-A''-octreotide in a somatostatin receptor-positive tumor-bearing rat model are presented for the validation of the novel agent.Keywords
This publication has 29 references indexed in Scilit:
- 213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal ModelClinical Cancer Research, 2006
- Identification of a Novel Prostate Tumor Target, Mindin/RG-1, for Antibody-Based Radiotherapy of Prostate CancerCancer Research, 2005
- NMR Studies Reveal Structural Differences between the Gallium and Yttrium Complexes of DOTA-d-Phe-Tyr3-octreotideJournal of Medicinal Chemistry, 2005
- Targeting of HER2 Antigen for the Treatment of Disseminated Peritoneal DiseaseClinical Cancer Research, 2004
- Somatostatin analogues: Multiple roles in cellular proliferation, neoplasia, and angiogenesisPharmacology & Therapeutics, 2004
- Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic ComplexesJournal of Medicinal Chemistry, 2004
- Labeling anti-HER2/neu Monoclonal Antibodies with 111In and 90Y Using a Bifunctional DTPA Chelating AgentCancer Biotherapy & Radiopharmaceuticals, 2003
- In VivoEvaluation of Bismuth-Labeled Monoclonal Antibody Comparing DTPA-Derived Bifunctional ChelatesCancer Biotherapy & Radiopharmaceuticals, 2001
- Somatostatin Analogues for Somatostatin-Receptor-Mediated Radiotherapy of CancerDigestion, 1996
- SomatostatinNew England Journal of Medicine, 1983